fdg pet-ct for differentiating benign from malignant j. 2010 ...2014)/february.pdffdg pet-ct for...

7
Abstract 18 F-fluorodeoxyglucose-positron emission tomog- raphy (FDG-PET/CT) is a useful technique for distinguishing malignant and benign lesions, although the occurrence of false- positive results in cases involving benign lesions is possible. We evaluated nine patients with mycobacterial infections who underwent FDG-PET/CT from April 2008 to July 2010. FDG- PET/CT was performed 1 _ 2h (during the early and late phases) after administration of FDG at a dose of 185 MBq/individual after fasting for at least 5h. Out of the nine patients, four were diagnosed with pulmonary nonmycobacterium tuberculosis, two with pulmonary tuberculosis, two with tuberculous lymph- adenopathy, and one with pleural tuberculoma. All patients had a maximum standardized uptake value (SUVmax) of >2.5, and the SUVmax increased from the early to the late phase. One lesion that occurred due to tuberculous pleurisy after treatment demonstrated high FDG uptake, similar to the other cases. It is difficult to distinguish mycobacterial infections from malignant diseases using FGD-PET alone ; hence, the use of high-resolution CT and bacteriological tests is required for diagnosis and distinction. Key words : 18 F-fluorodeoxyglucose-positron emission tomog- raphy : FDG-PET/CT, Tuberculosis, Non-tuberculous myco- bacterial infection, Mycobacteriosis, Pleural tuberculoma 1 Department of Respiratory Medicine, Respiratory Center, Toranomon Hospital, 2 Department of Radiology, and 3 Pathol- ogy, Toranomon Hospital, 4 Okinaka Memorial Institute for Medical Research, 5 Department of Clinical Radiology, Fukujuji Hospital, Japan Anti-Tuberculosis Association Correspondence to : Hironori Uruga, Department of Respi- ratory Medicine, Respiratory Center, Toranomon Hospital, 2 _ 2 _ 2, Toranomon, Minato-ku, Tokyo 105 _ 8470 Japan. (E-mail : [email protected]) --------Original Article-------- EVALUATION OF MYCOBACTERIAL INFECTIONS USING 18 F-FLUORODEOXYGLUCOSE-POSITRON EMISSION TOMOGRAPHY : RESULTS OF NINE CASES 1, 4 Hironori URUGA, 2 Makiko ISHIHARA, 1 Shigeo HANADA, 1 Hisashi TAKAYA, 1 Atsushi MIYAMOTO, 1 Nasa MOROKAWA, 3 Takeshi FUJII, 5 Atsuko KUROSAKI, and 1, 4 Kazuma KISHI

Upload: others

Post on 25-Sep-2020

5 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: FDG PET-CT for differentiating benign from malignant J. 2010 ...2014)/february.pdfFDG PET-CT for differentiating benign from malignant solitary pulmonary nodules in a TB endemic area

Evaluation of Mycobacterial Infection Using FDG-PET/CT/H.Uruga et al. 43

20) Sathekge MM, Maes A, Pottel H, et al. : Dual time-point FDG PET-CT for differentiating benign from malignant

solitary pulmonary nodules in a TB endemic area. S Afr Med J. 2010 ; 100 : 598‒601.

Abstract 18F-fl uorodeoxyglucose-positron emission tomog-raphy (FDG-PET/CT) is a useful technique for distinguishing malignant and benign lesions, although the occurrence of false-positive results in cases involving benign lesions is possible. We evaluated nine patients with mycobacterial infections who underwent FDG-PET/CT from April 2008 to July 2010. FDG-PET/CT was performed 1_2h (during the early and late phases) after administration of FDG at a dose of 185 MBq/individual after fasting for at least 5h. Out of the nine patients, four were diagnosed with pulmonary nonmycobacterium tuberculosis, two with pulmonary tuberculosis, two with tuberculous lymph-adenopathy, and one with pleural tuberculoma. All patients had a maximum standardized uptake value (SUVmax) of>2.5, and the SUVmax increased from the early to the late phase. One lesion that occurred due to tuberculous pleurisy after treatment demonstrated high FDG uptake, similar to the other cases. It is diffi cult to distinguish mycobacterial infections from malignant diseases using FGD-PET alone ; hence, the use

of high-resolution CT and bacteriological tests is required for diagnosis and distinction.

Key words : 18F-fl uorodeoxyglucose-positron emission tomog-raphy: FDG-PET/CT, Tuberculosis, Non-tuberculous myco-bacterial infection, Mycobacteriosis, Pleural tuberculoma

1Department of Respiratory Medicine, Respiratory Center, Toranomon Hospital, 2Department of Radiology, and 3Pathol-ogy, Toranomon Hospital, 4Okinaka Memorial Institute for Medical Research, 5Department of Clinical Radiology, Fukujuji Hospital, Japan Anti-Tuberculosis Association

Correspondence to: Hironori Uruga, Department of Respi-ratory Medicine, Respiratory Center, Toranomon Hospital, 2_ 2_ 2, Toranomon, Minato-ku, Tokyo 105_ 8470 Japan. (E-mail : [email protected])

--------Original Article--------

EVALUATION OF MYCOBACTERIAL INFECTIONS USING 18F-FLUORODEOXYGLUCOSE-POSITRON EMISSION TOMOGRAPHY:

RESULTS OF NINE CASES

1, 4Hironori URUGA, 2Makiko ISHIHARA, 1Shigeo HANADA, 1Hisashi TAKAYA, 1Atsushi MIYAMOTO, 1Nasa MOROKAWA, 3Takeshi FUJII, 5Atsuko KUROSAKI,

and 1, 4Kazuma KISHI

Page 2: FDG PET-CT for differentiating benign from malignant J. 2010 ...2014)/february.pdfFDG PET-CT for differentiating benign from malignant solitary pulmonary nodules in a TB endemic area

結核 第89巻 第 2 号 2014年 2 月50

Abstract [Objective] To evaluate the use of SPEED-OLIGO® MYCOBACTERIA (Vircell, Spain) in identifying Mycobacterium species. [Method] We examined 15 type or reference strains of mycobacteria (M.tuberculosis H37Rv and 14 non-tuberculosis mycobacteria), 48 clinical isolates, and 17 AFB-positive sputa by using SPEED-OLIGO® MYCOBACTERIA, and compared the results with those obtained using other referral methods available for species identifi cation. [Result] SPEED-OLIGO® MYCOBACTERIA yielded fa-vorable results in 80.0%, 91.7%, and 88.2% of the cases of the tested type/reference strains, clinical isolates, and clinical samples, respectively. However, the type/reference strains M.celatum, M.fortuitum subsp. fortuitum, and M.marinum, and the clinical isolates M.intermedium, M.marinum, and M.

szulgai were misidentifi ed when SPEED-OLIGO® MYCO-BACTERIA was used. [Discussion] SPEED-OLIGO® MYCOBACTERIA can fa-

cilitate the rapid identifi cation of Mycobacterium species mainly because of its short turn-around time and simple procedures. However, the accuracy of this method remains unsatisfactory.

Key words : Dipstick method, Mycobacterium identifi cation

1Bacteriology Division, Department of Mycobacterium Reference and Research, Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association, 2Department of Basic Mycobacteriosis, Nagasaki University Graduate School of Biomedical Sciences

Correspondence to: Kinuyo Chikamatsu, Bacteriology Divi-sion, Department of Mycobacterium Reference and Research, Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association, 3_ 1_ 24, Matsuyama, Kiyose-shi, Tokyo 204_

8533 Japan. (E-mail : [email protected])

--------Original Article--------

EVALUATION OF THE USE OF SPEED-OLIGO® MYCOBACTERIA FOR IDENTIFICATION OF MYCOBACTERIUM SPECIES

1Kinuyo CHIKAMATSU, 1Akio AONO, 1Hiroyuki YAMADA, 1, 2Tomoko KATO, and 1, 2Satoshi MITARAI

Page 3: FDG PET-CT for differentiating benign from malignant J. 2010 ...2014)/february.pdfFDG PET-CT for differentiating benign from malignant solitary pulmonary nodules in a TB endemic area

結核 第89巻 第 2 号 2014年 2 月56

Abstract The patient was a 27-year-old man with pulmo-nary tuberculosis, who was initially treated with isoniazid, rifampicin, ethambutol, and pyrazinamide. However, because of hepatic dysfunction and visual impairment, the four-drug therapy was switched to a three-drug regimen with isoniazid, rifampicin, and levofl oxacin. At 9 weeks after the initiation of levofl oxacin, the patient developed cervical lymphadenop-athy, fever, systemic erythema, and hepatic dysfunction. He was diagnosed with drug-induced hypersensitivity syndrome (DIHS) based on positive results in the human herpesvirus (HHV)-6 DNA test, an indicator of HHV-6 reactivation. The symptoms improved after withdrawal of the antituberculosis drugs and initiation of steroid administration. However, considering the risk of relapse of DIHS, the tuberculosis

treatment, which was initially planned for 9 months, was stopped at 7 months. Neither DIHS nor tuberculosis recurred.

Key words : Tuberculosis, Drug-induced hypersensitivity syn-drome, Levofl oxacin, Allergy, Multiple drug hypersensitivity

Department of Respiratory Medicine, National Hospital Organization Utsunomiya National Hospital

Correspondence to: Otohiro Katsube, Department of Respi-ratory Medicine, National Hospital Organization Utsunomiya National Hospital, 2160 Shimookamoto, Utsunomiya-shi, Tochigi 329_1193 Japan. (E-mail : [email protected])

--------Case Report--------

A CASE OF DRUG-INDUCED HYPERSENSITIVITY SYNDROME CAUSED BY LEVOFLOXACIN USED FOR TREATING PULMONARY TUBERCULOSIS

Otohiro KATSUBE, Makiko ANZAI, Yushi NOMURA, Naoya IKEDA, Hidenori TAKIZAWA, Yasuko KIKKAWA, and Toshio NUMAO

Page 4: FDG PET-CT for differentiating benign from malignant J. 2010 ...2014)/february.pdfFDG PET-CT for differentiating benign from malignant solitary pulmonary nodules in a TB endemic area

50

40

30

20

10

0

90

80

70

60

50

40

30

20

10

0

All TB findings

Prevalence of TB findings (%)

Tuberculin positive rate and BCG coverage (%)

Healed findingsCalcified lesionsBCG coverageTuberculin positive rate

15 20 25 30 35 40 45 50 55 60 65 70 75 Total

100

Fig. 3 Age-specifi c prevalence of TB radiological fi ndings to estimated prevalence of TB infected persons, tuberculin positive rate and BCG coverage in 1968 TB prevalence survey

結核 第89巻 第 2 号 2014年 2 月60

が得られないであろうか? 両領域の専門家の見解を聞

きたいものである。

 著者のCOI(confl icts of interest)開示:本論文発表内

容に関して特になし。

文   献

1) 厚生労働省エイズ動向委員会:平成24(2012)年エイ

ズ発生動向. 厚生労働省, 東京, 2012.2) 厚生省:結核実態調査Ⅵ(昭和43年). 結核予防会, 東京, 1970.

3) 結核研究所ホームページ. http://www.jata.or.jp

Abstract Co-infection of tuberculosis (TB) and HIV is a serious problem in most developing countries and in indus-trialized countries, co-infection of TB and HIV is seen mainly among migrant population. In case of Japan, the numbers of both new HIV infection and AIDS cases have been increasing except slight decline in both fi gures in 2012, however, the epidemiological situation of HIV and AIDS is still one of the lowest in the world, and among index diseases of AIDS, TB is 5th among Japanese. Based on prevalence of radiological TB fi ndings in the national TB prevalence survey in 1968 and the coverage of BCG vaccination, the author speculated that most TB primary infection took place among those with rather high delayed type sensitivity, thus formation of typical primary complex was rather rare and the number of tubercle bacilli in primary

complex and post-primary early disseminated lesions were few, and less risk of development of active TB even among HIV infected individuals.

Key words : Co-infection of TB and HIV, Prevalence of radiological TB fi ndings, Coverage of BCG vaccination, Age-specifi c tuberculin positive rate

1Japan Anti-Tuberculosis Association (JATA), 2Japan Founda-tion for AIDS Prevention (JFAP)

Correspondence to: Tadao Shimao, Japan Anti-Tuberculosis Association, 1_3_12, Misaki-cho, Chiyoda-ku, Tokyo 101_

0061 Japan.

--------Review Article--------

SPECULATION ON REASONS WHY CO-INFECTION OF TUBERCULOSIS AND HIV IS RATHER RARE IN JAPAN

1, 2Tadao SHIMAO

Page 5: FDG PET-CT for differentiating benign from malignant J. 2010 ...2014)/february.pdfFDG PET-CT for differentiating benign from malignant solitary pulmonary nodules in a TB endemic area

76 結核 第89巻 第 2 号 2014年 2 月

--------The 88th Annual Meeting Symposium--------

OUTPATIENT CARE OF TUBERCULOSIS

Chairpersons: 1Tetsuo YAMAGUCHI and 2Toshiaki FUJIKANE

Abstract The outpatient care is important still more in the treatment of tuberculosis (TB). The community DOTS is required, to accomplish the treatment of the TB patients those have various risks of treatment discontinuation.  In this symposium, the several points are reported. The number of TB hospitals are decreasing and are maldistributed. And even in TB hospitals, the person/time for the education of patient and the risk assessment of drug compliance, are not suffi cient. In general hospitals, the knowledge/experiences of TB treatment are not suffi cient. It is important to share the information of the TB patient, between the persons concerned. It is also important to notify and succeed the knowledge/experience regarding TB treatment. For outpatient care of TB, collaborating work in the area is necessary. As practical means,

it is important to promote the liaison critical path in the area. The TB hospital and the health center should play a big role.

Key words : Tuberculosis, Outpatient care, Community DOTS, Liaison critical path

1JR Tokyo General Hospital, 2National Hospital Organization Asahikawa Medical Center

Correspondence to: Toshiaki Fujikane, Department of Res-piratory Medicine, NHO Asahikawa Medical Center, 7 Hana-saki, Asahikawa-shi, Hokkaido 070_8644 Japan. (E-mail : [email protected])

Page 6: FDG PET-CT for differentiating benign from malignant J. 2010 ...2014)/february.pdfFDG PET-CT for differentiating benign from malignant solitary pulmonary nodules in a TB endemic area

Mini-Symposium/Tuberculosis Outbreak Cases 87

3) 豊田 誠:潜在性結核感染症治療による発病予防効果と発病時期の遅延について. 結核. 2013 ; 88 : 667‒670.

4) 豊田 誠:若年者を中心に複数の経路で拡大した結核

集団感染. 結核. 2012 ; 87 : 757‒763.5) 豊田 誠, 森岡茂治:化学予防中に INH耐性で発病した結核患者. 結核. 2001 ; 76 : 663‒666.

--------The 88th Annual Meeting Mini-Symposium--------

LESSONS LEARNED FROM TUBERCULOSIS OUTBREAK CASES

Chairpersons: 1Seiya KATO and 2Katsuhiro KUWABARA

Abstract Most TB outbreaks were caused by exposure of many people to tuberculosis bacilli due to delayed detection of initial cases who had long-lasting severe coughs and excretion of massive tuberculosis bacilli. They were also affected by several other factors, such as socio-environmental factors of the initial case; time and place of infection; and host factors of the infected persons such as immune status, infectivity, and/or pathogenicity of the bacilli. In this symposium, we learned the seriousness of infection and disease among immune-suppressed groups, special envi-ronmental factors with regard to the spread of infection, disease after treatment of latent tuberculosis infection, diagnostic specifi cation of IGRA, and bacteriological features including genotyping of the bacilli. We reaffi rmed that countermeasures for the case are impor-tant, but outbreaks can provide excellent opportunities to learn important information about infection, disease progression, etc.

1. Tuberculosis outbreak in a cancer ward : Katsuhiro KUWABARA (Division of Respiratory Diseases, National Hospital Organization Nishi-Niigata Chuo National Hospital) There was an outbreak of tuberculosis in a cancer ward of a highly specialized medical center. Outbreak cases included eight hospitalized patients and two medical staff members over a 1.5-year observation period after initial contact. Three immune-compromised patients including the index patent died of cancer and tuberculosis. Community hospitals and highly specialized medical centers, such as cancer centers, should carefully prepare a proper system to prevent nosoco-mial transmission of tuberculosis.

2. Sixty-one cases of TB exposures in hospital settings and contact investigations of the hospital staff, with special refer-ence to the application of QFT: Hiroko Yoshikawa NIGORI-KAWA (The Division of Infectious Diseases, Tokyo Metro-politan Health and Medical Treatment Corporation, Toshima Hospital ; present : Division of Infectious Diseases, Tokyo Teishin Hospital), Toru MORI (Research Institute of Tuber-culosis, Japan Anti-Tuberculosis Association) The index case was a patient who was admitted to a general hospital where she was treated with pulsed corticosteroid therapy and then put on a respirator. Soon after, she developed

tuberculosis (TB) and died. Immediately after her death, the healthcare workers who had close contact with the index case were given the QuantiFERON®TB Gold (QFT) test, which indicated that all staff except one were negative. However, a QFT test administered eight weeks later had a positive rate of 18.6%. Subsequently, a total of fi ve workers, including a doctor, nurses, and radiology technicians, developed TB. The bacterial isolates from fi ve of them exhibited an RFLP pattern identical to that of the index case. These secondary cases of TB included a case who had contact of less than 5 minutes, a case whose QFT was negative ( doubtful in the Japanese criterion of the QFT), and a case who was QFT-positive but declined to be treated for latent TB infection (LTBI). No other workers nor hospitalized patients developed TB. The healthcare worker contacts were further examined with the QFT 6, 9 and 12 months after the contact. The QFT results revealed four additional positive reactors and four doubtful reactors who were indicated for LTBI treatment. Among them were seven subjects who turned positive six months after the contact. TB prevention in hospital settings and contact investi-gations were discussed with the hospital staff, with special reference to the application of QFT.

3. Summary and issues of concern relating to a tuberculosis outbreak in a prison: Mitsunobu HOMMA, Takefumi ITOH (Department of Respiratory Medicine, Akita City Hospital) We report a tuberculosis outbreak that occurred in a prison in the spring of 2011, resulting in 11 cases of active disease and 40 cases of infection. The primary cause of the outbreak is thought to be the delay in identifying the index case, where the screening result interpretation might have contributed to the delay. However, we also speculate that environmental factors, such as occurrence in the closed space of a prison, inmates spending long periods living together, inmates staying in their rooms due to the cold winter, and poor ventilation in the prison factory, all contributed to accelerating the spread of the infec-tion. Both the QuantiFERON®TB-2G (QFT)-positive rate and disease incidence were higher among the close contact group, and there were no cases of tuberculosis among QFT-negative individuals, proving the utility of QFT screening in contact surveys. Genetic testing for Mycobacterium tuberculosis is a useful method for studying outbreak cases. In the present case, it led to the discovery of an unexpected route of infection,

Page 7: FDG PET-CT for differentiating benign from malignant J. 2010 ...2014)/february.pdfFDG PET-CT for differentiating benign from malignant solitary pulmonary nodules in a TB endemic area

88 結核 第89巻 第 2 号 2014年 2 月

reaffi rming its importance. This outbreak occurred among a particular population with whom it was diffi cult to deal and it occurred under unique circumstances. In fact, there were various obstacles to overcome, the most important of which was to ensure the three organizations involved (prisons, health centers, and hospitals) worked together closely, sharing accurate, real-time information.

4. Environmental factors, treatment for latent tuberculosis infection and molecular epidemiology relating to an outbreak of tuberculosis : Makoto TOYOTA (Kochi City Public Health Center), Seiya KATO (Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association) The ventilation rate within the room of a junior high school was analyzed using sulfur hexafl uoride (SF6) as the tracer gas. Low ventilation of the room contributed to the massive out-break. The risk of active tuberculosis was reduced by 81.0% with treatment for latent tuberculosis infection, compared with that without treatment. Delayed reactivation of tuberculosis

was observed among patients treated with isoniazid for latent tuberculosis infection. Molecular epidemiology can provide insights into the process of tuberculosis transmission, which may otherwise go unrecognized by conventional contact investigations. Additionally, it can play an important role in identifying places of tuberculosis outbreaks and routes of transmission in a contact investigation.

Key words : Tuberculosis, Outbreak, Hospital, Prison, School

1Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association, 2Division of Respiratory Diseases, National Hos-pital Organization Nishi-Niigata Chuo National Hospital

Correspondence to: Seiya Kato, Research Institute of Tuber-culosis, Japan Anti-Tuberculosis Association, 3_1_24, Matsu-yama, Kiyose-shi, Tokyo 204_8533 Japan. (E-mail : [email protected])